GPT and liver disorder: As expected, patients with progressive liver disease showed higher levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, gamma-glutamyl-transferase (GGT), controlled attenuation parameter (CAP), and CK18-M65.